Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
PIMAVANSERIN
(2016)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
PIMAVANSERIN
×
Maximum Phase:
4
First Approval:
2016
UNII:
JZ963P0DIK
Molecule Type:
Small molecule
Molecular Formula:
C25H34FN3O2
Molecular Weight:
427.56
AlogP:
4.67
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
8.0
Source:
OBETICHOLIC ACID
(2016)
Small molecule
Bile acid receptor FXR agonist
ORAL
Approved
Cholangitis; Liver Cirrhosis, Biliary
OBETICHOLIC ACID
×
Maximum Phase:
4
First Approval:
2016
UNII:
0462Z4S4OZ
Molecule Type:
Small molecule
Molecular Formula:
C26H44O4
Molecular Weight:
420.63
AlogP:
5.11
PSA:
77.76
HBD:
3.0
HBA:
#RotB:
5.0
Source:
PRASTERONE
(2016)
Small molecule
Unknown
VAGINAL
Approved
Arthritis, Rheumatoid; Dysmenorrhea; Hypogonadism; Klinefelter Syndrome; Neoplasms; Orchitis; Osteoarthritis; Pain
PRASTERONE
×
Maximum Phase:
4
First Approval:
2016
UNII:
459AG36T1B
Molecule Type:
Small molecule
Molecular Formula:
C19H28O2
Molecular Weight:
288.43
AlogP:
3.88
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CRISABOROLE
(2016)
Small molecule
Phosphodiesterase 4 inhibitor
TOPICAL
Approved
Dermatitis, Atopic; Eczema
CRISABOROLE
×
Maximum Phase:
4
First Approval:
2016
UNII:
Q2R47HGR7P
Molecule Type:
Small molecule
Molecular Formula:
C14H10BNO3
Molecular Weight:
251.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RUCAPARIB CAMSYLATE
(2016)
Small molecule
PARP 1, 2 and 3 inhibitor
ORAL
Approved
Ovarian Neoplasms
RUCAPARIB CAMSYLATE
×
Maximum Phase:
4
First Approval:
2016
UNII:
41AX9SJ8KO
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN3O5S
Molecular Weight:
555.67
AlogP:
2.98
PSA:
56.92
HBD:
3.0
HBA:
#RotB:
3.0
Source:
EPHEDRINE SULFATE
(2016)
Small molecule
Adrenergic receptor agonist
INTRAVENOUS
Approved
Asthma; Common Cold; Hypotension; Nasal Obstruction; Rhinitis, Allergic, Seasonal
EPHEDRINE SULFATE
×
Maximum Phase:
4
First Approval:
2016
UNII:
U6X61U5ZEG
Molecule Type:
Small molecule
Molecular Formula:
C20H32N2O6S
Molecular Weight:
428.55
AlogP:
1.33
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FLUCICLOVINE F18
(2016)
Small molecule
Diagnostic agent
Unknown
Approved
Unknown
FLUCICLOVINE F18
×
Maximum Phase:
4
First Approval:
2016
UNII:
38R1Q0L1ZE
Molecule Type:
Small molecule
Molecular Formula:
C6H10FNO2
Molecular Weight:
146.15
AlogP:
0.29
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
LIFITEGRAST
(2016)
Small molecule
Integrin alpha-L/beta-2 (LFA-1) antagonist
OPHTHALMIC
Approved
Dry Eye Syndromes; Eye Diseases
LIFITEGRAST
×
Maximum Phase:
4
First Approval:
2016
UNII:
038E5L962W
Molecule Type:
Small molecule
Molecular Formula:
C29H24Cl2N2O7S
Molecular Weight:
615.49
AlogP:
4.77
PSA:
133.99
HBD:
2.0
HBA:
#RotB:
7.0
Source:
METHYLENE BLUE
(2016)
Small molecule
Reducing agent
INTRAVENOUS
Approved
Urinary Tract Infections
METHYLENE BLUE
×
Maximum Phase:
4
First Approval:
2016
UNII:
T42P99266K
Molecule Type:
Small molecule
Molecular Formula:
C16H24ClN3O3S
Molecular Weight:
373.91
AlogP:
2.5
PSA:
19.14
HBD:
0.0
HBA:
#RotB:
1.0
Source:
RUCAPARIB
(2016)
Small molecule
PARP 1, 2 and 3 inhibitor
Unknown
Approved
Neoplasms
RUCAPARIB
×
Maximum Phase:
4
First Approval:
2016
UNII:
8237F3U7EH
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O
Molecular Weight:
323.37
AlogP:
2.98
PSA:
56.92
HBD:
3.0
HBA:
#RotB:
3.0
Source:
VALBENAZINE TOSYLATE
(2017)
Small molecule
Synaptic vesicular amine transporter inhibitor
ORAL
Approved
Tardive Dyskinesia
VALBENAZINE TOSYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
5SML1T733B
Molecule Type:
Small molecule
Molecular Formula:
C38H54N2O10S2
Molecular Weight:
762.99
AlogP:
3.56
PSA:
74.02
HBD:
1.0
HBA:
#RotB:
7.0
Source:
NERATINIB MALEATE
(2017)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Breast Neoplasms
NERATINIB MALEATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
9RM7XY23ZS
Molecule Type:
Small molecule
Molecular Formula:
C34H33ClN6O7
Molecular Weight:
673.13
AlogP:
5.93
PSA:
112.4
HBD:
2.0
HBA:
#RotB:
11.0
Source:
COPANLISIB HYDROCHLORIDE
(2017)
Small molecule
PI3-kinase p110-alpha subunit inhibitor
Unknown
Approved
Lymphoma, Follicular
COPANLISIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
03ZI7RZ52O
Molecule Type:
Small molecule
Molecular Formula:
C23H30Cl2N8O4
Molecular Weight:
553.45
AlogP:
0.66
PSA:
139.79
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SECNIDAZOLE
(2017)
Small molecule
DNA inhibitor
ORAL
Approved
Infections; Trichomonas Infections; Vaginosis, Bacterial
SECNIDAZOLE
×
Maximum Phase:
4
First Approval:
2017
UNII:
R3459K699K
Molecule Type:
Small molecule
Molecular Formula:
C7H11N3O3
Molecular Weight:
185.18
AlogP:
0.48
PSA:
81.19
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SAFINAMIDE
(2017)
Small molecule
Monoamine oxidase B inhibitor
Unknown
Approved
Parkinson Disease
SAFINAMIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
90ENL74SIG
Molecule Type:
Small molecule
Molecular Formula:
C17H19FN2O2
Molecular Weight:
302.35
AlogP:
2.37
PSA:
64.35
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TELOTRISTAT ETHYL
(2017)
Small molecule
Tryptophan 5-hydroxylase inhibitor
Unknown
Approved
Unknown
TELOTRISTAT ETHYL
×
Maximum Phase:
4
First Approval:
2017
UNII:
8G388563M7
Molecule Type:
Small molecule
Molecular Formula:
C27H26ClF3N6O3
Molecular Weight:
574.99
AlogP:
4.99
PSA:
131.17
HBD:
2.0
HBA:
#RotB:
9.0
Source:
MACIMORELIN ACETATE
(2017)
Small molecule
Ghrelin receptor agonist
ORAL
Approved
Unknown
MACIMORELIN ACETATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
AQZ1003RMG
Molecule Type:
Small molecule
Molecular Formula:
C28H34N6O5
Molecular Weight:
534.62
AlogP:
1.84
PSA:
144.9
HBD:
6.0
HBA:
#RotB:
10.0
Source:
PITAVASTATIN MAGNESIUM
(2017)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Dyslipidemias; Hyperlipidemias
PITAVASTATIN MAGNESIUM
×
Maximum Phase:
4
First Approval:
2017
UNII:
BDS8LUQ384
Molecule Type:
Small molecule
Molecular Formula:
C50H46F2MgN2O8
Molecular Weight:
865.22
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ABEMACICLIB
(2017)
Small molecule
Cyclin-dependent kinase 4 inhibitor
ORAL
Approved
Breast Neoplasms; Neoplasms
ABEMACICLIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
60UAB198HK
Molecule Type:
Small molecule
Molecular Formula:
C27H32F2N8
Molecular Weight:
506.61
AlogP:
4.94
PSA:
75.0
HBD:
1.0
HBA:
#RotB:
7.0
Source:
VOXILAPREVIR
(2017)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Approved
Hepatitis C, Chronic
VOXILAPREVIR
×
Maximum Phase:
4
First Approval:
2017
UNII:
0570F37359
Molecule Type:
Small molecule
Molecular Formula:
C42H58F2N6O9S
Molecular Weight:
861.02
AlogP:
5.35
PSA:
195.22
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DUTETRABENAZINE
(2017)
Small molecule
Synaptic vesicular amine transporter inhibitor
Unknown
Approved
Chorea; Huntington Disease
DUTETRABENAZINE
×
Maximum Phase:
4
First Approval:
2017
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H27NO3
Molecular Weight:
323.47
AlogP:
3.24
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
4.0
Source:
LETERMOVIR
(2017)
Small molecule
DNA terminase inhibitor
INTRAVENOUS; ORAL
Approved
Cytomegalovirus Infections; Infections; Virus Diseases
LETERMOVIR
×
Maximum Phase:
4
First Approval:
2017
UNII:
1H09Y5WO1F
Molecule Type:
Small molecule
Molecular Formula:
C29H28F4N4O4
Molecular Weight:
572.56
AlogP:
5.71
PSA:
77.84
HBD:
1.0
HBA:
#RotB:
6.0
Source:
SAFINAMIDE MESYLATE
(2017)
Small molecule
Monoamine oxidase B inhibitor
ORAL
Approved
Parkinson Disease
SAFINAMIDE MESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
YS90V3DTX0
Molecule Type:
Small molecule
Molecular Formula:
C18H23FN2O5S
Molecular Weight:
398.46
AlogP:
2.37
PSA:
64.35
HBD:
2.0
HBA:
#RotB:
7.0
Source:
OZENOXACIN
(2017)
Small molecule
DNA gyrase inhibitor
TOPICAL
Approved
Impetigo
OZENOXACIN
×
Maximum Phase:
4
First Approval:
2017
UNII:
V0LH498RFO
Molecule Type:
Small molecule
Molecular Formula:
C21H21N3O3
Molecular Weight:
363.42
AlogP:
3.76
PSA:
84.22
HBD:
2.0
HBA:
#RotB:
4.0
Source:
DEFLAZACORT
(2017)
Small molecule
Glucocorticoid receptor agonist
ORAL
Approved
Muscular Dystrophies; Muscular Dystrophy, Duchenne
DEFLAZACORT
×
Maximum Phase:
4
First Approval:
2017
UNII:
KR5YZ6AE4B
Molecule Type:
Small molecule
Molecular Formula:
C25H31NO6
Molecular Weight:
441.52
AlogP:
2.56
PSA:
102.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
GLECAPREVIR
(2017)
Small molecule
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Unknown
Approved
Hepatitis C, Chronic
GLECAPREVIR
×
Maximum Phase:
4
First Approval:
2017
UNII:
K6BUU8J72P
Molecule Type:
Small molecule
Molecular Formula:
C38H46F4N6O9S
Molecular Weight:
838.88
AlogP:
3.86
PSA:
195.22
HBD:
3.0
HBA:
#RotB:
6.0
Source:
HYDROGEN PEROXIDE
(2017)
Small molecule
Unknown
TOPICAL
Approved
Gingivitis; Infections; Keratosis, Seborrheic; Pharyngitis
HYDROGEN PEROXIDE
×
Maximum Phase:
4
First Approval:
2017
UNII:
BBX060AN9V
Molecule Type:
Small molecule
Molecular Formula:
H2O2
Molecular Weight:
34.01
AlogP:
0.02
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
MIDOSTAURIN
(2017)
Small molecule
Platelet-derived growth factor receptor inhibitor
ORAL
Approved
Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Mastocytosis; Mastocytosis, Systemic; Neoplasms
MIDOSTAURIN
×
Maximum Phase:
4
First Approval:
2017
UNII:
ID912S5VON
Molecule Type:
Small molecule
Molecular Formula:
C35H30N4O4
Molecular Weight:
570.65
AlogP:
5.91
PSA:
77.73
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PITAVASTATIN SODIUM
(2017)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Dyslipidemias; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II
PITAVASTATIN SODIUM
×
Maximum Phase:
4
First Approval:
2017
UNII:
29556RBN9P
Molecule Type:
Small molecule
Molecular Formula:
C25H23FNNaO4
Molecular Weight:
443.45
AlogP:
4.52
PSA:
90.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
ENASIDENIB
(2017)
Small molecule
Unknown
Unknown
Approved
Neoplasms
ENASIDENIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
3T1SS4E7AG
Molecule Type:
Small molecule
Molecular Formula:
C19H17F6N7O
Molecular Weight:
473.38
AlogP:
4.29
PSA:
108.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
ENASIDENIB MESYLATE
(2017)
Small molecule
Isocitrate dehydrogenase [NADP], mitochondrial inhibitor
ORAL
Approved
Leukemia, Myeloid, Acute
ENASIDENIB MESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
UF6PC17XAV
Molecule Type:
Small molecule
Molecular Formula:
C20H21F6N7O4S
Molecular Weight:
569.49
AlogP:
4.29
PSA:
108.74
HBD:
3.0
HBA:
#RotB:
6.0
Source:
VABORBACTAM
(2017)
Small molecule
Carbepenem-hydrolyzing beta-lactamase KPC inhibitor
Unknown
Approved
Urinary Tract Infections
VABORBACTAM
×
Maximum Phase:
4
First Approval:
2017
UNII:
1C75676F8V
Molecule Type:
Small molecule
Molecular Formula:
C12H16BNO5S
Molecular Weight:
297.14
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
NERATINIB
(2017)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Approved
Neoplasms
NERATINIB
×
Maximum Phase:
4
First Approval:
2017
UNII:
JJH94R3PWB
Molecule Type:
Small molecule
Molecular Formula:
C30H29ClN6O3
Molecular Weight:
557.05
AlogP:
5.93
PSA:
112.4
HBD:
2.0
HBA:
#RotB:
11.0
Source:
NETARSUDIL DIMESYLATE
(2017)
Small molecule
Rho-associated protein kinase inhibitor
OPHTHALMIC
Approved
Glaucoma, Open-Angle; Ocular Hypertension
NETARSUDIL DIMESYLATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
VL756B1K0U
Molecule Type:
Small molecule
Molecular Formula:
C30H35N3O9S2
Molecular Weight:
645.76
AlogP:
4.89
PSA:
94.31
HBD:
2.0
HBA:
#RotB:
7.0
Source:
CALCIUM GLUCONATE
(2017)
Small molecule
Mineral supplement
INTRAVENOUS
Approved
Hypocalcemia
CALCIUM GLUCONATE
×
Maximum Phase:
4
First Approval:
2017
UNII:
SQE6VB453K
Molecule Type:
Small molecule
Molecular Formula:
C12H22CaO14
Molecular Weight:
430.37
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
COCAINE
(2017)
Small molecule
Unknown
Unknown
Approved
Unknown
COCAINE
×
Maximum Phase:
4
First Approval:
2017
UNII:
I5Y540LHVR
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO4
Molecular Weight:
303.36
AlogP:
1.87
PSA:
55.84
HBD:
0.0
HBA:
#RotB:
3.0
Source:
1
2
…
66
67
68
69
70
71
72
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA